Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/29/1998 | US5853697 Methods of treating established colitis using antibodies against IL-12 |
12/29/1998 | US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
12/24/1998 | CA2234418A1 Human afc1 |
12/24/1998 | CA2234402A1 Human rce1 |
12/23/1998 | WO1998057976A1 Secreted proteins and polynucleotides encoding them |
12/23/1998 | WO1998057972A1 Quaternary ammonium compounds as tachykinin antagonists |
12/23/1998 | WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds |
12/23/1998 | WO1998057954A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
12/23/1998 | WO1998057939A1 Crystalline roxifiban |
12/23/1998 | WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
12/23/1998 | WO1998042868A3 Screening method for proline-rich proteins |
12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |
12/23/1998 | EP0885299A1 Wsx receptor and ligands |
12/23/1998 | EP0885221A1 Azabicyclic esters of carbamic acids useful in therapy |
12/23/1998 | EP0885215A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
12/23/1998 | EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
12/23/1998 | EP0885190A1 Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
12/23/1998 | EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
12/23/1998 | CN1202894A Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
12/23/1998 | CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists |
12/23/1998 | CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds |
12/23/1998 | CN1202821A Compositions and methods for buccal delivery of pharmaceutical agent |
12/23/1998 | CN1202373A Chinese herbal medicine formula for curing icterohepatitis A |
12/23/1998 | CN1202368A Chinese drug composition for curing gastritis and other stomachache |
12/23/1998 | CN1041309C Method for preparing piperidine derivatives |
12/23/1998 | CA2294569A1 Secreted proteins and polynucleotides encoding them |
12/23/1998 | CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds |
12/23/1998 | CA2294047A1 Crystalline roxifiban |
12/23/1998 | CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
12/23/1998 | CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
12/23/1998 | CA2241164A1 Apo b-secretion/mtp inhibitor hydrochloride salt |
12/22/1998 | US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
12/22/1998 | US5852052 Treatment of lyso paf-mediated mental or neuronal disorders with lyso paf or paf antagonists and procedure for determining their efficacy |
12/22/1998 | US5852031 2,7-substituted octahydro-1H-pyrido 1,2-a!pyrazine derivatives |
12/22/1998 | US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same |
12/22/1998 | US5852004 Drug and pharmaceutical composition for the treatment of lesions of the digestive tract |
12/22/1998 | US5851999 FLK-1 is a receptor for vascular endothelial growth factor |
12/22/1998 | US5851989 Method of extending the plasma half-life of vascular endothelial cell growth factor |
12/22/1998 | US5851987 Human tumor-associated Kazal inhibitor-like polypeptides and encoding polynucleotides |
12/22/1998 | US5851814 Human elastate IV |
12/22/1998 | US5851786 Product and process to regulate actin polymerization |
12/22/1998 | US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies |
12/22/1998 | US5851513 Antiplaque oral composition and method |
12/18/1998 | CA2239605A1 Novel g-protein coupled receptor (h7tba62) |
12/17/1998 | WO1998056909A2 Secreted proteins and polynucleotides encoding them |
12/17/1998 | WO1998056821A1 Alpha 1-antitrypsin preparation and method for the production thereof |
12/17/1998 | WO1998056820A1 Hm74a receptor |
12/17/1998 | WO1998056398A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
12/17/1998 | WO1998056387A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein |
12/17/1998 | WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | WO1998056364A1 IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE |
12/17/1998 | WO1998056360A2 Film-coated tablet for improved upper gastrointestinal tract safety |
12/17/1998 | WO1998056356A1 Therapeutically active compositions |
12/17/1998 | WO1998040069A3 Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
12/17/1998 | WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
12/17/1998 | CA2294057A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | CA2293363A1 Secreted proteins and polynucleotides encoding them |
12/17/1998 | CA2292628A1 Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride |
12/17/1998 | CA2291645A1 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
12/16/1998 | EP0884319A2 [1,3]oxazino[3,2-A]indole derivative |
12/16/1998 | EP0884316A1 Quinazoline-4-one AMPA antagonists |
12/16/1998 | EP0884310A1 Quinazolin-4-one ampa antagonists |
12/16/1998 | EP0883622A1 Proton pump inhibitor |
12/16/1998 | EP0883606A1 Process for scavenging thiols |
12/16/1998 | EP0883405A1 Amidino protease inhibitors |
12/16/1998 | EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
12/16/1998 | CN1202164A Diarylalkenylamine derivatives |
12/16/1998 | CN1202103A Excitatory amino acid receptor antagonists |
12/16/1998 | CN1201673A Wolfberry powder and production thereof |
12/16/1998 | CN1041166C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in obtaining of antiulcer, complexes and chelates |
12/15/1998 | US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant |
12/15/1998 | US5849919 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor anonist activity |
12/15/1998 | US5849896 α-subunit of the Mac-1 leukocyte adhesion receptor |
12/15/1998 | US5849799 Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases |
12/15/1998 | US5849781 Tricyclic amides |
12/15/1998 | US5849774 Treatment of sepsis-induced acute renal failure |
12/15/1998 | US5849770 Tri-substituted phenyl derivatives useful as PDE IV inhibitors |
12/15/1998 | US5849761 Peripherally active anti-hyperalgesic opiates |
12/15/1998 | US5849760 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors |
12/15/1998 | US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists |
12/15/1998 | US5849705 Method for the treatment of Schwann cells in vivo |
12/15/1998 | US5849696 Composition and method of treating hepatitis C |
12/15/1998 | US5849689 Method of extending the plasma half-life of deletion variants of hepatocyte growth factor |
12/15/1998 | US5849686 Morphogen-induced liver regeneration |
12/15/1998 | US5849322 Compositions and methods for buccal delivery of pharmaceutical agents |
12/15/1998 | US5849295 Nucleotide sequences coding for a protein with urease activity |
12/15/1998 | CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
12/15/1998 | CA2144513C Morphogen-induced periodontal tissue regeneration |
12/11/1998 | CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor |
12/10/1998 | WO1998055620A1 Ntn-2 member of tnf ligand family |
12/10/1998 | WO1998055476A1 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, preparation and therapeutic use |
12/10/1998 | WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines |
12/10/1998 | WO1998055131A1 Pharmaceutical preparation comprising lactobacillus casei rhamnosus |
12/10/1998 | WO1998055126A2 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases |
12/10/1998 | WO1998055118A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
12/10/1998 | WO1998054982A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids |
12/10/1998 | WO1998035967A3 Biazacyclic crf antagonists |
12/10/1998 | CA2294547A1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
12/10/1998 | CA2292746A1 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, preparation and therapeutic use |
12/10/1998 | CA2292536A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids |